You will be required to enroll in Calibrate and see a Calibrate clinician
Research is largely limited to animal injury models, and BPC-157 is prohibited in sport under anti-doping rules
Last month, Wegovy received FDA approval for a new indication for use to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight
Health authorities discourage the use of BPC-157 due to insufficient human safety data, and it is not approved by any drug regulatory agency for human use
However, others may experience the opposite, especially after weight loss improves body image and confidence
Individuals with certain medical conditions (such as kidney disease, heart conditions, or fluid restrictions) or those who are pregnant should consult with a medical provider before treatment